Dolby Laboratories (NYSE:DLB – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, November 16th. Analysts expect the company to announce earnings of $0.52 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Dolby Laboratories Trading Down 0.1 %
Shares of DLB opened at $85.85 on Thursday. The stock has a market capitalization of $8.21 billion, a P/E ratio of 38.16 and a beta of 1.00. The firm’s fifty day simple moving average is $81.64 and its two-hundred day simple moving average is $83.10. Dolby Laboratories has a 12 month low of $65.18 and a 12 month high of $91.01.
In other news, CMO Todd Pendleton sold 6,889 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $84.41, for a total transaction of $581,500.49. Following the completion of the transaction, the chief marketing officer now directly owns 36,976 shares of the company’s stock, valued at $3,121,144.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CMO Todd Pendleton sold 6,889 shares of the company’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $84.41, for a total transaction of $581,500.49. Following the completion of the transaction, the chief marketing officer now owns 36,976 shares in the company, valued at $3,121,144.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Kevin J. Yeaman sold 18,060 shares of the stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $82.62, for a total transaction of $1,492,117.20. Following the transaction, the chief executive officer now owns 51,879 shares of the company’s stock, valued at approximately $4,286,242.98. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,979 shares of company stock valued at $2,816,967. Corporate insiders own 39.25% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
DLB has been the topic of a number of analyst reports. Rosenblatt Securities upped their target price on shares of Dolby Laboratories from $93.00 to $98.00 and gave the stock a “buy” rating in a report on Friday, August 4th. TheStreet lowered shares of Dolby Laboratories from a “b” rating to a “c+” rating in a research note on Friday, August 4th. Finally, StockNews.com assumed coverage on shares of Dolby Laboratories in a research note on Thursday, October 5th. They issued a “hold” rating for the company. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and a consensus target price of $107.00.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
- Five stocks we like better than Dolby Laboratories
- Are Penny Stocks a Good Fit for Your Portfolio?
- Investing in large cap stocks: Diving into big caps
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why you can make Vertex Pharmaceuticals a buy on any pullback
- Dividend Capture Strategy: What You Need to Know
- Occidental Petroleum: Another bounce from the buy zone
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.